Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones ...

A lymph node–targeted delivery platform releases antibody therapy only in tumor-like conditions, strengthening immune attack ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could ...

Cancer cells undergo physically constraining processes, such as intravasation, extravasation, and tissue infiltration, that lead to acute mechanical stress. How mechanical confinement rewires the ...

A new method can produce specially designed proteins that can arm T cells to attack cancer cells. Precision personalized cancer treatment on a larger scale has come a step closer after researchers ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth ...